Evidence map›Paper›PMID 32540969›Full record

ArticleThe Journal of biological chemistry2020

Effects of intron conversion in the human

Brahmaraju Mopidevi, Indu Sivankutty, Shoujin Hao, Nicholas R Ferreri, Ashok Kumar

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Brahmaraju MopideviDepartment of Pathology, New York Medical College, Valhalla, New York, USA.
Indu SivankuttyDepartment of Pathology, New York Medical College, Valhalla, New York, USA.
Shoujin HaoDepartment of Pharmacology, New York Medical College, Valhalla, New York, USA.
Nicholas R FerreriDepartment of Pharmacology, New York Medical College, Valhalla, New York, USA.ORCID 0000-0001-5097-9956
Ashok KumarDepartment of Pathology, New York Medical College, Valhalla, New York, USA akumar5@nymc.edu.
New York Medical College · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Aldosterone Synthase & HypertensionR01HL122742 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI KUMAR, ASHOK · 2014 to 2017
$2.5M
Non-Coding Variants of Angiotensinogen Gene and HypertensionR01HL130344 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI KUMAR, ASHOK · 2016 to 2019
$2.4M
NCI NIH HHS P30 CA023108NHLBI NIH HHS R01 HL122742NHLBI NIH HHS R01 HL130344
6 · The paper itself

Abstract

The human cytochrome P450 family 11 subfamily B member 2 (

Indexed as

IntronsAldosteroneAnimalsBlood PressureCytochrome P-450 CYP11B2Genes, ReporterHumansMiceMice, TransgenicRNA, MessengerTranscription, GeneticAldosteroneCytochrome P-450 CYP11B2RNA, Messengeraldosterone synthasecardiovascular diseasecytochrome P450 family 11 subfamily B member 2 (CYP11B2)gene expressiongeneticshypertensionintron conversionrenin-angiotensin systemsingle‐nucleotide polymorphism (SNP,)transgenic mice

Identifiers

PMID32540969
PMCPMC7415971
OpenAlexW3035536614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.